WCA
Windsor Creek Advisors’s CRISPR Therapeutics CRSP Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q3 | – | Sell |
-6,000
| Closed | -$971K | – | 116 |
|
|
2021
Q2 | $971K | Buy |
6,000
+1,500
| +33% | +$243K | 0.25% | 81 |
|
|
2021
Q1 | $548K | Buy |
4,500
+1,000
| +29% | +$122K | 0.14% | 102 |
|
|
2020
Q4 | $536K | Buy |
+3,500
| New | +$536K | 0.14% | 108 |
|
|
2020
Q3 | – | Sell |
-5,000
| Closed | -$367K | – | 145 |
|
|
2020
Q2 | $367K | Sell |
5,000
-19,472
| -80% | -$1.43M | 0.12% | 87 |
|
|
2020
Q1 | $1.04M | Buy |
24,472
+19,472
| +389% | +$826K | 0.37% | 54 |
|
|
2019
Q4 | $305 | Buy |
+5,000
| New | +$305 | 0.08% | 85 |
|